Content
All Posts > Content under Pharma/Biotech
Bulls And Bears Of The Week: Apple, Nike, Tesla, Uber And More
3 Dividend Stocks Retirees Must Have In Their Portfolio
Article By:
SureDividend
Read
Sunday, July 7, 2019 2:18 AM EDT
Investing in strong dividend growers will help you live a stress-free retirement. Even if we are currently trading at an all-time high, Mr. Market offers us a few great opportunities. Here are my favorites right now.
Week In Review: Jibeier Pharma Files To Raise $100 Million In IPO On New Shanghai STAR Board
Article By:
ChinaBio® Today
Read
Sunday, July 7, 2019 12:07 AM EDT
Jibeier Pharma, expects to raise $100 million in the offering. The company, plans to use the funds to build a new drug manufacturing facility and R&D center, and to support its R&D of new drugs along with clinical trials.
Bulls & Bears Of The Week: AT&T, Carnival, McDonald's, Microsoft And More
How Facebook Inc And Other Hedge Fund Favorites Performed In Q2
Article By:
Insider Monkey
Read
Saturday, June 29, 2019 6:00 PM EDT
The #1 most popular stock among the 743 hedge funds tracked by Insider Monkey was Facebook Inc (Nasdaq:FB). Facebook was the third most popular stock among hedge funds at the end of December.
Week In Review: Tasly Bio Files For $1 Billion Hong Kong IPO
Article By:
ChinaBio® Today
Read
Saturday, June 29, 2019 5:19 PM EDT
Shanghai Tasly Biopharma, the biologics arm of Tasly Pharma, has filed a prospectus for a Hong Kong IPO expected to raise up to $1 billion.
In this article: JNJ
American Depositary Receipts
Article By:
Vivian Lewis
Read
Thursday, June 27, 2019 12:01 AM EDT
The medical devices firm Smith & Nephew pondered creating an ADR listing in order to pay their new CEO Narnal Nawana a higher salary than would have been tolerated by UK shareholders. And more on global stocks.
In this article: ANFGF, CRH, GNCGY, MELI, NPSNY, TCEHY, AAIGF, TEVA, AGN, ZYME, VOD, CGEN, GNFTF, BHC, BT, AQN, DCMYY, AZRE, FBASF, GLD
Artelo Biosciences Announces Pricing Of $8.0 Million Public Offering And Uplisting To Nasdaq
Article By:
NASDAQ GlobeNewswire
Read
Saturday, June 22, 2019 10:30 PM EDT
In connection with the offering, the Company has effectuated a reverse split of its common stock at a ratio of 1-for-8.
In this article: ARTL
Week In Review: Immunotherapies Dominate The Week's China Biopharma News
Article By:
ChinaBio® Today
Read
Saturday, June 22, 2019 4:19 PM EDT
Beijing's BeiGene will receive a $150 million termination fee as Celgene ends its $1.4 billion co-development partnership for BeiGene's PD-1 candidate.
Biotech Stocks Getting Ready To Explode
Article By:
Tarun Chandra, CFA
Read
Monday, June 17, 2019 11:38 AM EDT
Biotech shares are up this year, as represented by the Nasdaq Biotechnology Index (IBB), which is the industry benchmark, and the S&P Select Biotechnology Index (XBI), after a sharp decline in 2018. This is a welcome respite for biotech investors.
The Stock Market Is Pointing To A Higher Opening On June 17
Article By:
Michael J. Kramer
Read
Monday, June 17, 2019 10:09 AM EDT
S&P 500 Futures are flirting with a rise above resistance at 2,900 on June 17. We can also see the futures are now trending higher, which is a positive. Biotech stocks should get a shot in the arm today and more...
Week In Review: China Biopharma Announces Nearly $3 Billion In Deals
Article By:
ChinaBio® Today
Read
Saturday, June 15, 2019 4:33 PM EDT
Vivo Capital, a US-China healthcare investor, raised $1.3 billion for its ninth fund, bringing its assets under management to more than $4.3 billion. Hansoh Pharma staged a $1 billion Hong Kong IPO and then rising 37% in its first trading session.